New patent for Boehringer Ingelheim drug PRADAXA

February 25, 2021 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for PRADAXA Pradaxa is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from three suppliers. There are five patents…

The post New patent for Boehringer Ingelheim drug PRADAXA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.